Resource Center
Resource Center
On World AIDS Day, we reflect on the growing inequalities in access to essential HIV services that many countries face - and work being done to close the gap.
Read moreCHAI releases the 12th issue of our annual HIV market report. This report provides a detailed look at the complex, ever-changing HIV commodity markets in low- and middle-income countries based on aggregated market intelligence from our work in over 30 countries.
Read moreThe strawberry-flavored formulation of the WHO’s recommended first-line treatment for HIV is designed to overcome many of the barriers that stop young children taking their medication properly.
Read moreUnitaid, the Clinton Health Access Initiative, and Laurus Labs announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children.
Read moreA full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Read moreA long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries, thanks to a landmark agreement from Unitaid and the Clinton Health Access Initiative (CHAI).
Read moreFive things to know about DTG as the long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries.
Read moreThe report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
Read moreCHAI is pleased to release the 10th issue of our annual HIV Market Report: The state of HIV treatment, testing, and prevention in low- and middle-income countries. The report provides a detailed look at the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work...
Read more